MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Leukemia Research
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

253 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
253 works in the cohort · of 4,299,418page 5 of 6

Labels cover 0 of 253 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 253 of 253 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundno abstractunlabeled
Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols
Maria Kondyli, David-Étienne Tremblay, Aziz Rezgui, Sophie Annaelle Serfaty, Vincent Gagné, Maïté Ribère +5 more
2021· letter· en· Leukemia Research· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · metaepi_narrow+research_integrity
1
citations
affaboutno abstractunlabeled
Corrigendum to “Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update” [Leukemia Research 125 (2023) 107016]
Carolyn Owen, Versha Banerji, Nathalie A. Johnson, Alina S. Gerrie, Andrew Aw, Christine Chen +1 more
2023· erratum· en· Leukemia Research· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+bibliometrics+sts+research_integrity+insufficient_payloadconsensus · metaepi_narrow+research_integrity+insufficient_payload
0
citations
affno abstractunlabeled
TREATMENT - CURRENT TREATMENT OPTIONS - HIGHER RISK MDS
Clarissa Skorupski, Lisa Chodirker, Lee Mozessohn, James T. England, Theodore A. Kennedy, Matthew C. Cheung +9 more
2025· article· en· Leukemia Research· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
0
citations
affno abstractunlabeled
Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation – Post-transplantation treatment: IN VIVO DUAL T CELL DEPLETION (TCD) IMPROVES TRANSPLANT OUTCOMES IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS WHO UNDERGO MATCHED UNRELATED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Anas Ali Sayyed, M. Altareb, C. Chen, A. Gerbitz, D. Kim, W. Lam +8 more
2023· article· en· Leukemia Research· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
0
citations
affno abstractunlabeled
Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: RANDOMIZED PHASE 2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS
G. Garcia-Manero, K. Bachiashvili, E. Griffiths, E. Traer, L. Saini, H. Amin +28 more
2023· article· en· Leukemia Research· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrowconsensus · none
0
citations
affno abstractunlabeled
Corrigendum to “Patient-driven research: Initial results from a prospective health–related quality of life study performed at the request of patients living with hairy cell leukemia” [Leuk. Res. 120 (2022) 106919]
Mirela Anghelina, Michelle J. Naughton, Qiuhong Zhao, Amy S. Ruppert, Jasmine Neal, Kerry A. Rogers +12 more
2022· erratum· en· Leukemia Research· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+sts+open_science+research_integrity+insufficient_payloadconsensus · metaepi_narrow+sts+research_integrity
0
citations
affno abstractunlabeled
TREATMENT - CURRENT TREATMENT OPTIONS - HIGHER RISK MDS
Uwe Platzbecker, Valeria Santini, Amer M. Zeidan, Mikkael A. Sekeres, Pierre Fenaux, Azra Raza +14 more
2025· article· en· Leukemia Research· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
0
citations
← previousnext →

How this was built: Screen · Findings · About